Desktop Site
|
26 Apr 24 | 15:11
|
Open
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
*
Notices
|
S&P
BSE SENSEX
73,667.76
-671.68
-0.90 %
Corporate Announcement
Security Code
530019
Company
Jubilant Pharmova Ltd
Exchange Disseminated Time
Announces Q3 Results, Results Press Release, Investors Presentation & Limited Review Report for Dec 31, 2014 |
02/03/15 15:54
Jubilant Life Sciences Ltd has announced the following results for the quarter ended December 31, 2014:
The Un-Audited Standalone results for the Quarter ended December 31, 2014
The Company has posted a net (loss) of Rs. (84.80) million for the quarter ended December 31, 2014 as compared to Net Profit of Rs. 1645.20 million for the quarter ended December 31, 2013. Total Income has decreased from Rs. 9574.10 million for the quarter ended December 31, 2013 to Rs. 7411.90 million for the quarter ended December 31, 2014.
The Consolidated Results are as follows:
The Unaudited Consolidated results for the Quarter ended December 31, 2014
The Group has posted a net profit/(loss) after taxes, minority interest and share of profit/loss of associates of Rs. (111.60) million for the quarter ended December 31, 2014 as compared to net profit of Rs. 1434.30 million for the quarter ended December 31, 2013. Total Income has increased from Rs. 14484.90 million for the quarter ended December 31, 2013 to Rs. 14515.30 million for the quarter ended December 31, 2014.
<< Back
Recently Viewed